
Tamglow 0.4mg Tablet
Marketer
Glowsun India Labs Pvt Ltd
Salt Composition
Tamsulosin (0.4mg)
Overview Tamglow 0.4mg Tablet
Alfuzosin 0.4mg tablets, an alpha-blocker, are indicated for managing benign prostatic hyperplasia (BPH). This medication alleviates urinary symptoms such as hesitancy, but doesn't shrink the prostate gland. Always adhere to your physician's prescribed dosage and duration. It can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may exacerbate symptoms, so complete the prescribed course. Optimal therapeutic outcomes require adherence to the full treatment regimen. Common side effects include lightheadedness, back discomfort, chest pain, ejaculatory dysfunction, and retrograde ejaculation. Persistent or bothersome side effects warrant immediate medical attention. Lifestyle modifications can improve symptom control. Urinate promptly when the urge arises, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Prior to commencing treatment, disclose all current medications and health conditions to your doctor. If cataract or glaucoma surgery is planned, inform your ophthalmologist about your Alfuzosin use. Individuals with hepatic impairment require careful monitoring and regular check-ups as directed by their doctor.
Uses of Tamglow 0.4mg Tablet
Managing benign prostatic hyperplasia
Major Benefits of Tamglow 0.4mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the 0.4mg Tamglow tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Tamglow 0.4mg Tablet:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Tamglow 0.4mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 0.4mg Tamglow tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Tamglow 0.4mg Tablet works:
Tamglow 0.4mg tablets contain an alpha-adrenergic blocking agent. Its mechanism of action involves relaxing the bladder neck and prostatic smooth muscle, facilitating easier urination. This promotes complete bladder emptying and lessens urinary frequency and urgency associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Tamglow 0.4mg tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The effects of Tamglow 0.4mg Tablet on pregnancy are undocumented. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Tamglow 0.4mg Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Tamglow 0.4mg Tablet is contraindicated in women.
DrivingSAFE
Driving ability is typically unaffected by Tamglow 0.4mg tablets.
KidneySAFE IF PRESCRIBED
Tamglow 0.4mg tablets may be used by individuals with kidney impairment without altering the prescribed dosage. Nevertheless, data regarding its use in patients with advanced kidney disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tamglow 0.4mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tamglow 0.4mg Tablet :
Should you forget to take your Tamglow 0.4mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tamglow 0.4mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Sulfonamide-based compound |
| Developing Habits | No. |
| Type of Therapy | Urological Care |
